跳转至内容
Merck
CN
所有图片(1)

文件

07-539

Sigma-Aldrich

抗乙酰组蛋白H3(Lys4)抗体

Upstate®, from rabbit

别名:

H3K4Ac, Histone H3 (acetyl K4)

登录查看公司和协议定价


About This Item

UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物来源

rabbit

质量水平

抗体形式

affinity isolated antibody

抗体产品类型

primary antibodies

克隆

polyclonal

纯化方式

affinity chromatography

种属反应性

human

制造商/商品名称

Upstate®

技术

ChIP: suitable (ChIP-seq)
dot blot: suitable
inhibition assay: suitable (peptide)
multiplexing: suitable
western blot: suitable

同位素/亚型

IgG

NCBI登记号

UniProt登记号

运输

wet ice

靶向翻译后修饰

acetylation (Lys 4)

基因信息

human ... H3F3B(3021)

特异性

组蛋白H3在Lys4上乙酰化时
预计具有广泛的物种交叉反应性

免疫原

KLH偶联合成肽包含序列 ...RT[AcK]Q...,其中[AcK]对应于人组蛋白H3的乙酰赖氨酸4

应用

建议的稀释度:
蛋白质印迹:1:1000 - 1:10,000
抗乙酰基组蛋白H3(Lys 4)抗体是一种兔多克隆抗体,用于检测乙酰基组蛋白H3(Lys 4),也称为H3K4Ac,组蛋白H3(乙酰基K4)& 已在Mplex、WB、PIA、ChIP、ChIP-seq、DB中得到验证。
研究子类别
组蛋白
研究类别
表观遗传学&核功能

质量

已通过免疫印迹进行常规评估。

目标描述

Mr ~17kDa

外形

100 μL免疫亲和纯化的兔IgG,溶于在含有0.1 M Tris-甘氨酸(pH 7.4)和0.15 M NaCl,并含有0.05%叠氮化钠和30%甘油的缓冲液中
免疫亲和纯化

储存及稳定性

自运送之日起在-20°C下保存1年

法律信息

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

Not finding the right product?  

Try our 产品选型工具.

WGK

WGK 1


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Federico Forneris et al.
The Journal of biological chemistry, 281(46), 35289-35295 (2006-09-22)
Human lysine-specific demethylase (LSD1) is a chromatin-modifying enzyme that specifically removes methyl groups from mono- and dimethylated Lys4 of histone H3 (H3-K4). We used a combination of in vivo and in vitro experiments to characterize the substrate specificity and recognition
Runsheng He et al.
Nucleic acids research, 45(11), 6427-6441 (2017-04-13)
Epigenetic regulation of chromatin plays a critical role in controlling embryonic stem (ES) cell self-renewal and pluripotency. However, the roles of histone demethylases and activating histone modifications such as trimethylated histone 3 lysine 4 (H3K4me3) in transcriptional events such as
Cheng-Yu Yang et al.
Oncotarget, 8(20), 33756-33769 (2017-04-20)
Aberrant activation of histone lysine-specific demethylase (LSD1) increases tumorigenicity; hence, LSD1 is considered a therapeutic target for various human cancers. Although melatonin, an endogenously produced molecule, may defend against various cancers, the precise mechanism involved in its anti-oral cancer effect
Ya-Wei Chen et al.
Cancer, 119(24), 4259-4267 (2013-12-05)
Patterns of global histone modifications have been suggested to be predictors of clinical outcome in many cancers. However, the role of global histone modification patterns in oral squamous cell carcinoma (OSCC) is unclear. A retrospective clinicopathologic analysis was undertaken of
Oral administration of the pimelic diphenylamide HDAC inhibitor HDACi 4b is unsuitable for chronic inhibition of HDAC activity in the CNS in vivo.
Beconi, M; Aziz, O; Matthews, K; Moumne, L; O'Connell, C; Yates, D; Clifton, S; Pett et al.
Testing null

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门